Niagen Bioscience, Inc. (NAGE)
NASDAQ: NAGE · Real-Time Price · USD
3.420
+0.110 (3.32%)
At close: Jun 26, 2026, 4:00 PM EDT
3.450
+0.030 (0.88%)
After-hours: Jun 26, 2026, 7:46 PM EDT
Niagen Bioscience Employees
Niagen Bioscience had 117 employees as of December 31, 2025. The number of employees increased by 13 or 12.50% compared to the previous year.
Employees
117
Change (1Y)
13
Growth (1Y)
12.50%
Revenue / Employee
$1,114,667
Profits / Employee
$159,291
Market Cap
272.95M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Bicycle Therapeutics | 288 |
| Entrada Therapeutics | 152 |
| Adagene | 128 |
| Nautilus Biotechnology | 127 |
| Invivyd | 122 |
| Zentalis Pharmaceuticals | 106 |
| Cartesian Therapeutics | 75 |
| InflaRx | 65 |
NAGE News
- 16 days ago - Niagen Bioscience Transcript: 16th Annual East Coast IDEAS Conference - Transcripts
- 24 days ago - Niagen Bioscience to Present at the 16th Annual East Coast IDEAS Investor Conference - Business Wire
- 25 days ago - Niagen Bioscience renames CERP to Niagen Research Program - TheFly
- 25 days ago - Niagen Bioscience Renames ChromaDex External Research Program to the Niagen Research Program, Strengthening Position as the Global Leader in NAD+ Science - Business Wire
- 6 weeks ago - Niagen Bioscience price target lowered to $11 from $12 at H.C. Wainwright - TheFly
- 7 weeks ago - Niagen Bioscience Announces Participation in Upcoming Investor Conferences - Business Wire
- 7 weeks ago - Niagen Bioscience price target lowered to $12 from $13 at Roth Capital - TheFly
- 7 weeks ago - Niagen Bioscience reports Q1 EPS 7c, consensus 6c - TheFly